Dementia among overlooked conditions linked to high risk of severe COVID-19 in older people

by University of ExeterCredit: CC0 Public DomainA new analysis shows which certain pre-existing diseases may put older people at risk of developing more severe COVID-19, implying they may need sp

Updated on: May 11,2024

Dementia among overlooked conditions linked to high risk of severe COVID-19 in older people

by University of ExeterCredit: CC0 Public DomainA new analysis shows which certain pre-existing diseases may put older people at risk of developing more severe COVID-19, implying they may need sp

Updated on:May 11,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on: March 07,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on:March 07,2024

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on: December 12,2024

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on:December 12,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on: February 28,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on:February 28,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on: April 10,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on:April 10,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on: December 17,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on:December 17,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on: November 27,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on:November 27,2024

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on: March 09,2024

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on:March 09,2024

Impact of Transfusion Strategies on Neurological Recovery in Acute Brain Injury: Insights from a Multicenter Randomized Trial

Updated on: January 09,2025

Impact of Transfusion Strategies on Neurological Recovery in Acute Brain Injury: Insights from a Multicenter Randomized Trial

Updated on:January 09,2025

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024